22nd Century Group, Inc. Company Profile
Founded in 1998, 22nd Century Limited, LLC (22nd Century) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company owns or exclusively controls 98 issued patents in 79 countries where at least 75% of the worldâs smokers reside. 22nd Century is committed to developing and commercializing (i) the worldâs most effective and acceptable smoking cessation aid and (ii) for those smokers who refuse to quit smoking, consumer-acceptable modified risk tobacco products that reduce exposure to smoke toxins, as compared to conventional cigarettes. Through a merger on January 25, 2011, 22nd Century became a wholly-owned subsidiary of 22nd Century Group, Inc.
News Articles
22nd Century Group completes private placement of convertible preferred stock and warrants
22nd Century Group Investors Convert $1.7 Million of Notes into Common Stock
22nd Century Group, Inc. (OTCBB: XXII) announced today that its balance sheet has been greatly strengthened through the elimination of more than $3 million of debt over the past...
22nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels
22nd Century Group, Inc. (OTCBB: XXII), a company that has developed groundbreaking technology for tobacco harm reduction and smoking cessation products, today announced that the...
22nd Century Group, Inc. (OTCBB: XXII) today announced that its subsidiary Goodrich Tobacco Company has entered into an exclusive distribution agreement with Wilshire Marketing BV...
22nd Century Group Announces Allowance of U.S. Patent for MPO Nicotine Biosynthesis Gene
22nd Century Group, Inc. (OTCBB: XXII), a company that has developed groundbreaking technology for tobacco harm reduction and smoking cessation products, today announced that the...
22nd Century Group Announces U.S. Patent Issues for MPO Nicotine Biosynthesis Gene
22nd Century Group, Inc. (OTCBB: XXII), a company that has developed groundbreaking technology for tobacco harm reduction products, today announced that the United States Patent a...
22nd Century Group, Inc. (OTCBB: XXII) announced today that its subsidiary, Goodrich Tobacco Company, LLC (Goodrich Tobacco) applied to the Alcohol and Tobacco Tax Trade Bureau...
Chinese and Australian Patents Allowed for 22nd Century’s NBB Nicotine Biosynthesis Gene
22nd Century Group, Inc. (OTCBB: XXII), a company that has developed groundbreaking technology for tobacco harm reduction and smoking cessation products, today announced that the...
Drugs and Medications
Di-dak-sol [Century Pharmaceuticals, Inc.]
didaksol
Avva [Eastern Century Pharmaceuticals]
Avva Vaginal Douche Gel
Guardian [Eastern Century Pharmaceuticals]
Guardian Gel Vaginal Douche
Dakins full [Century Pharmaceuticals, Inc.]
dakinsfull
Dakins quarter [Century Pharmaceuticals, Inc.]
dakinsquarter
PubMed Articles
Vaccines for the twenty-first century society.
Vaccines have been one of the major revolutions in the history of mankind and, during the twentieth century, they eliminated most of the childhood diseases that used to cause millions of deaths. In th...
STUDY DESIGN.: Cross-sectional surveys of health-related quality of life (QOL) in subjects with low back pain and knee pain using a population-based cohort. OBJECTIVE.: The purpose of the present stud...
A history of joint puncture and injection.
Up until the middle of the 20th century joint puncture was considered a dangerous surgical intervention performed primarily to drain pus. The differential diagnostic significance of synovial analysis...
Diagnosis and Management of Type I and Type V Hyperlipoproteinemia.
Both type I and type V hyperlipoproteinemia are characterized by severe hypertriglyceridemia due to an increase in chylomicrons. Type I hyperlipoproteinemia is caused by a decisive abnormality of the...
Twenty-first century vaccines.
In the twentieth century, vaccination has been possibly the greatest revolution in health. Together with hygiene and antibiotics, vaccination led to the elimination of many childhood infectious diseas...
Clinical Trials
Actions Elicited by In-hospital Follow-up of Cardiac Devices
This study will enroll all patients who will attend an in-hospital follow-up of cardiac device since February 22nd 2010 to June 21st 2010. Primary objective of the study is to observe how...
Genomic Investigation of Cardiovascular Diseases
This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research a...
Herbal Treatment of Hepatitis C in Methadone Maintained Patients
Hepatitis C (HCV) is a chronic viral illness leading to progressive liver damage that has emerged as a major public health issue in the United States. While HCV affects all population grou...
A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus
Postoperative ileus (POI), a transient impairment of gastrointestinal (GI) motility, commonly occurs in patients who have undergone abdominal surgery and contributes to postoperative morbi...
The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...
Companies
Founded in 1998, 22nd Century Limited, LLC (22nd Century) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkal...
Founded in 1998, 22nd Century is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant t...
The Century Council is a national not-for-profit organization dedicated to fighting drunk driving and underage drinking and is funded by the following distillers: Bacardi U.S.A.,...
21st Century Oncology is the premier provider of cancer care services across multiple modalities, the largest radiation oncology provider and the second largest group of urologist...
Based on the theories of Chinese traditional and Western medicine, combining with modern medical and bioengineering techniques, MEDITALENT GROUP is engaged to be the Character of?Modernization of Chin...
More Information about "22nd Century Group, Inc." on BioPortfolio
We have published hundreds of 22nd Century Group, Inc. news stories on BioPortfolio along with dozens of 22nd Century Group, Inc. Clinical Trials and PubMed Articles about 22nd Century Group, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 22nd Century Group, Inc. Companies in our database. You can also find out about relevant 22nd Century Group, Inc. Drugs and Medications on this site too.
